Navigation Links
Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
Date:7/5/2011

SUNNYVALE, Calif., July 5, 2011 /PRNewswire/ -- Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced that the Drug Discovery Division of Genetix will join Molecular Devices.

(Logo:  http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)

With the addition of Genetix, Molecular Devices continues to grow as a leading technology supply company for research, biotechnology, and pharmaceutical customers around the world.

Research in Pharma/Biotech is shifting toward biotherapeutic drugs (antibodies, proteins, and vaccines).  Two key products from Genetix, the ClonePix™ and QPix™ instrument platforms, address cell lines used in biotherapeutic research.  ClonePix is an automated mammalian cell selection platform that significantly expedites the process of identifying and selecting cells that produce biotherapeutic candidates, reducing both time and cost.

In addition, the CloneSelect™ Imager and CellReporter from Genetix will extend Molecular Devices' imaging portfolio. These products offer a good value for a budget conscious end user.

Commenting on the move, Mark Verheyden, President of Molecular Devices said, "We are excited about welcoming Genetix into the Molecular Devices team, knowing that the combined business will be better positioned to serve our customers."

About Molecular Devices, Inc.

At Molecular Devices we have one focus—our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire creative, best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dedicated follow-on support. Understanding your laboratory workflow is our top priority, and we direct product development toward solving your unique issues. Our instruments offer a full spectrum of detection technologies and meet all throughput needs—from dedicated, single-readout devices to multi-readout systems. Our goal is to deliver highly relevant analytical products to detect biology, decode data, and drive discovery. With headquarters in Silicon Valley and offices around the globe, we support and enrich efforts of the international BioResearch, BioPharma, and BioTesting communities. Visit us today at www.MolecularDevices.com.

Molecular Devices products are for Research Use Only. Not for use in diagnostic procedures.

Molecular Devices, the Molecular Devices logo, and all other trademarks are the property of Molecular Devices, Inc.

About Genetix

Founded in 1991, Genetix offers cell selection and cell imaging instrumentation and related products to basic and applied research scientists. The product range has been rebranded to carry the Molecular Devices name.


'/>"/>
SOURCE Molecular Devices Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Imagenetix, Inc. Reports Third Quarter 2011 Results
2. Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011
3. Imagenetix Announces Issuance of New U.S. Patent for the Prevention and Treatment of Periodontal Disease
4. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
5. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
6. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
7. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
8. Radient Pharmaceuticals Corporation Joins OTCQX
9. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
10. Dr. F. John Mills Joins Intelsius Board of Directors as Non-Executive Chair
11. Mr. Charlie Alvarez Joins the Board of Sanomedics International Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  The Baylor ... received an in-kind gift from ... VeinViewer® Vision vein finder for the nursing ... students as they learn how to start ... with traditional technique. ...
(Date:2/10/2016)... Feb. 10, 2016  Visage Imaging Inc. ("Visage"), ... (ASX: PME), has announced that the American College of ... have selected the Visage 7 Enterprise Imaging Platform ... Emergent/Critical Care Imaging SIMulation (SIM). SIM is the ... Program (WIDI), a multi-faceted and fully-integrated online assessment, ...
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... , ... Emergency rooms provide emergency care to stabilize critical health issues, but ... dental emergencies at risk of losing a tooth or their smiles. Dr. Marine Martirosyan, ... dental emergencies include:, , Avulsed or knocked-out teeth , ...
(Date:2/10/2016)... Missouri (PRWEB) , ... February 10, 2016 , ... ... in San Diego, will bring together more than 200 of the country’s top ... for the future. , “The true benefit of the Forum is the provider-centric ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... time Emmy award winner and inspirational speaker Jan Fox will serve as keynote ... Speaking Boldly will provide participants with tools to more effectively communicate with their ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... Everseat digital self-scheduling readily available to physicians. The integration will enable ... find and select appointments via Everseat’s free mobile app. , The partnership gives ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... The recreational ... cannabis enthusiasts in the state still face a lot of restrictions as to where ... is intended for private, personal use” and that cannabis “may not be consumed openly ...
Breaking Medicine News(10 mins):